Bluejay Diagnostics, Inc. (BJDX) is a Healthcare stock trading at $4.44 (as of 2026-06-18), with a market capitalization of $884435.00 and a trailing P/E of -0.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Bluejay Diagnostics, Inc. develops and sells the Symphony platform, including the Symphony analyzer for whole-blood processing, biomarker isolation, and immunoassay preparation, along with Symphony Cartridges containing reagents and components. It also provides the ALLEREYE point-of-care diagnostic test for allergic conjunctivitis and develops Symphony IL-6 tests for critical care monitoring.